Flego, V., Ristić, S., Dević Pavlić, S., Matanić Lender, D., Bulat Kardum, Lj. i Radojčić Badovinac, A. (2013). Tumor necrosis factor-alpha gene promoter -308 and -238 polymorphisms in patients with lung cancer as a second primary tumor. Medical Science Monitor, 19., 845-851. doi: 10.12659/MSM.889554
Flego, Veljko, et al. "Tumor necrosis factor-alpha gene promoter -308 and -238 polymorphisms in patients with lung cancer as a second primary tumor." Medical Science Monitor, vol. 19, 2013, str. 845-851. https://doi.org/10.12659/MSM.889554
Flego, Veljko, Smiljana Ristić, Sanja Dević Pavlić, Dubravka Matanić Lender, Ljiljana Bulat Kardum i Anđelka Radojčić Badovinac. "Tumor necrosis factor-alpha gene promoter -308 and -238 polymorphisms in patients with lung cancer as a second primary tumor." Medical Science Monitor 19 (2013): 845-851. https://doi.org/10.12659/MSM.889554
Flego, V., et al. (2013) 'Tumor necrosis factor-alpha gene promoter -308 and -238 polymorphisms in patients with lung cancer as a second primary tumor', Medical Science Monitor, 19, str. 845-851. doi: 10.12659/MSM.889554
Flego V, Ristić S, Dević Pavlić S, Matanić Lender D, Bulat Kardum Lj, Radojčić Badovinac A. Tumor necrosis factor-alpha gene promoter -308 and -238 polymorphisms in patients with lung cancer as a second primary tumor. Medical Science Monitor [Internet]. 2013. [pristupljeno 08.10.2024.];19:845-851. doi: 10.12659/MSM.889554
V. Flego, S. Ristić, S. Dević Pavlić, D. Matanić Lender, Lj. Bulat Kardum i A. Radojčić Badovinac, "Tumor necrosis factor-alpha gene promoter -308 and -238 polymorphisms in patients with lung cancer as a second primary tumor", Medical Science Monitor, vol. 19, str. 845-851, 2013. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:614906. [Citirano: 08.10.2024.]